Toby O Smith1, Ashwini Sreekanta2, Sarah Walkeden3, Bridget Penhale4, Sarah Hanson5. 1. Faculty of Medicine and Health Sciences, University of East Anglia, Norwich, UK; Nuffield Department of Orthopaedics Rheumatology & Musculoskeletal Sciences, University of Oxford, UK. Electronic address: toby.smith@uea.ac.uk. 2. Faculty of Medicine and Health Sciences, University of East Anglia, Norwich, UK. Electronic address: Ashwini.sreekanta@uea.ac.uk. 3. Physiotherapy Department, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK. Electronic address: sarah.walkenden@nnuh.nhs.uk. 4. Faculty of Medicine and Health Sciences, University of East Anglia, Norwich, UK. Electronic address: bridget.penhale@uea.ac.uk. 5. Faculty of Medicine and Health Sciences, University of East Anglia, Norwich, UK. Electronic address: sarah.hanson@uea.ac.uk.
Abstract
PURPOSE: To determine the effectiveness of hospital-based interventions designed to reduce Hospital-Associated Deconditioning (HAD) for people in inpatient hospital settings. MATERIALS & METHODS: Systematic literature search of published and unpublished databases was conducted from (inception to 01 June 2020). Randomised and non-randomised controlled trials investigating the effectiveness of enhanced inpatient programmes aimed to reduce HAD in adults admitted to a hospital ward were included. Evidence was appraised using the Cochrane Risk of Bias tool and outcomes evaluated against the GRADE criteria. Where appropriate, data were pooled in meta-analyses and presented as risk difference (RD) or standardised mean difference with 95 % confidence intervals (CI). RESULTS: Seven studies recruiting 12,597 participants (7864 enhanced programmes; 4349 usual care) were included. There was low-quality evidence for reduced risk of decline in physical performance for those in the enhanced programmes compared to usual care (RD: -0.04; 95 % CI: -0.08 to -0.01; N = 2085). There was low- or very-low quality evidence reporting no benefit of enhanced programmes for mobility on discharge, length of hospital stay, hospital readmission, and mortality within the first three-months post-admission (p > 0.05). There was low-quality evidence that nursing home placement and mortality at 12-months was superior through enhanced inpatient programmes compared to usual care. CONCLUSION: Enhanced inpatient programmes targeted at HAD may offer benefit over usual care for some outcomes. There remain uncertainty in relation to how applicable the findings are to non-North American countries, which elements of an enhanced programme are most important to reduce HAD, and longer-term sequelae.
PURPOSE: To determine the effectiveness of hospital-based interventions designed to reduce Hospital-Associated Deconditioning (HAD) for people in inpatient hospital settings. MATERIALS & METHODS: Systematic literature search of published and unpublished databases was conducted from (inception to 01 June 2020). Randomised and non-randomised controlled trials investigating the effectiveness of enhanced inpatient programmes aimed to reduce HAD in adults admitted to a hospital ward were included. Evidence was appraised using the Cochrane Risk of Bias tool and outcomes evaluated against the GRADE criteria. Where appropriate, data were pooled in meta-analyses and presented as risk difference (RD) or standardised mean difference with 95 % confidence intervals (CI). RESULTS: Seven studies recruiting 12,597 participants (7864 enhanced programmes; 4349 usual care) were included. There was low-quality evidence for reduced risk of decline in physical performance for those in the enhanced programmes compared to usual care (RD: -0.04; 95 % CI: -0.08 to -0.01; N = 2085). There was low- or very-low quality evidence reporting no benefit of enhanced programmes for mobility on discharge, length of hospital stay, hospital readmission, and mortality within the first three-months post-admission (p > 0.05). There was low-quality evidence that nursing home placement and mortality at 12-months was superior through enhanced inpatient programmes compared to usual care. CONCLUSION: Enhanced inpatient programmes targeted at HAD may offer benefit over usual care for some outcomes. There remain uncertainty in relation to how applicable the findings are to non-North American countries, which elements of an enhanced programme are most important to reduce HAD, and longer-term sequelae.
Authors: K Lambe; S Guerra; G Salazar de Pablo; S Ayis; I D Cameron; N E Foster; E Godfrey; C L Gregson; F C Martin; C Sackley; N Walsh; K J Sheehan Journal: BMC Geriatr Date: 2022-06-11 Impact factor: 4.070